Skip to content
Great news for kids: OSSIOfiber® Metal-Free Compression Screws and Trimmable Fixation Nails are now FDA cleared for various bone fractures in children (ages 2-12) and adolescents (ages 12-21). Read More
20230418 121638 1 Scaled Ossio – Naturally Transformative Bone Healing

Who We Are

Our Mission:

OSSIO® strives to become THE gold standard in orthopedic fixation by encouraging natural bone healing that will ultimately eliminate hardware removal procedures, minimize implant-related complications, alleviate pain, and dramatically improve the healthcare economics of orthopedics.

We are committed to transforming the orthopedic experience for patients, physicians, and payors. Our vision is to provide the first credible replacement to metal implants in the $15B+ orthopedic fixation market (screws, pins, plates) with Intelligent Bone Regeneration Technology. OSSIOfiber® represents a breakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.

Our Story

Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation: “Bio-Integrative” implants that have both the desired strength AND bio-friendliness. Implants that have the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables” and other “bio-composites”), have remained elusive to the industry — until now.

OSSIO® has its commercial headquarters in Boston, Massachusetts and development & manufacturing headquarters in Caesarea, Israel. We are a young, fast-growing company that is always on the lookout for talented people to join our multidisciplinary team. If you are highly motivated and inspired to heal bone better, please send your CV and cover letter to info@ossio.io

Leadership, Innovation, And Experience

Brian Verrier

Brian Verrier

Chief Executive Officer

Orahn Preiss-Bloom

Orahn Preiss-Bloom

Founder & Chief Innovation Officer

Brennan Marilla

Brennan Marilla

Chief Commercial and Operating Officer

Moshe Shneor

Moshe Shneor

Chief Financial Officer

Taly Lindner, Ph.d.

Taly Lindner, Ph.D.

Vice President, Scientific & Regulatory Affairs

Ronit Merchav-Feuermann, Dvm

Ronit Merchav-Feuermann, DVM

Vice President, Clinical & Medical Affairs

Dani Bar-Lev

Dani Bar-Lev

Vice President, Quality Assurance

Gregory C. Berlet, Md, Frcs(C), Faoa

Gregory C. Berlet, MD, FRCS(C), FAOA

Chief Medical Officer

Jonathan Bar

Jonathan Bar

Vice President, Operations

Tal Zeevi

Tal Zeevi

Vice President, R&D

Board of Directors

Gary J. Pruden

Gary J. Pruden

Kerry Assil, Md

Kerry Assil, MD

Hemi Zucker

Hemi Zucker

Steven Reeders

Steven Reeders

Mayur Tipnis

Mayur Tipnis

Kevin Cheng

Kevin Cheng

Brian Verrier

Brian Verrier

Interested in OSSIOfiber®?

Complete the form and an OSSIOfiber® Advisor will get in touch.

Customer Service

For product inquiries or purchasing questions contact 833-781-7373 or email info@ossio.io

Address

Commercial Headquarters
OSSIO Inc
300 Tradecenter Drive, Suite 3690
Woburn, MA, 01801

Science & Manufacturing Center

OSSIO Ltd.
8 HaTochen Street
Cesarea, Israel 3079861

OSSIOfiber® has been used by over 900 surgeons across the US

Footnotes

1. Data on file at OSSIO 2. Clinical study data on file at OSSIO 3. Kaiser, P.B., Watkins, I., Riedel, M. D., Cronin, P., Briceno, J., Kron, J. Y. (2019). Implant Removal Matrix for the Foot and Ankle Orthopaedic Surgeon. Foot & Ankle Specialist, 12(1), 79-97. https://doi.org/10.1177/1938640018791015 4. Pre-clinical animal studies (in-bone implantation of OSSIOfiber® and PLDLA control in rabbit femurs). Data on File at OSSIO.